[HTML][HTML] A review of inactivated COVID-19 vaccine development in China: focusing on safety and efficacy in special populations
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A review of inactivated COVID-19 vaccine development in China: focusing on safety and efficacy in special populations.
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - 2023 - cabidigitallibrary.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - europepmc.org
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
[HTML][HTML] A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao… - Vaccines, 2023 - search.ebscohost.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - search.proquest.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao… - …, 2023 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations.
L Hu, J Sun, Y Wang, D Tan, Z Cao, L Gao, Y Guan… - Vaccines, 2023 - europepmc.org
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has been widespread globally, and …